Abuhashish is a research assistant at the Cambridge (UK)-based company bit.bio. She holds a master's degree in biomedicine from the Karolinska institute and the University of Uppsala.

Abuhashish works on planning, performing, and evaluating genetic screens to identify and activate reprogramming factors in HiPSC and mammalian cell lines using the Opti-Ox technology. She also works on supporting the technological development of existing and novel screening techniques/platforms and helps coordinating the implementation of new technologies and SOPs as pertains to the team (Discovery Screening) and company (bit.bio)-wide Objectives and Key Results (OKRs).

Abuhashish is focused on developing a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine as it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human diseases (e.g., Huntingdon’s Disease and Frontotemporal Dementia (FTD).